Lakefront Biotherapeutics (GLPGF) Asset Utilization Ratio (2016 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Asset Utilization Ratio for 10 consecutive years, with 0.31 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 389.87% year-over-year to 0.31 in Q1 2026; TTM through Mar 2026 was 0.31, a 389.87% increase from a year earlier, with the FY2025 full-year figure at 0.3, up 363.68% from the prior year.
• Asset Utilization Ratio was 0.31 for Q1 2026 at Lakefront Biotherapeutics, down from 0.32 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.32 in Q4 2025 and troughed at 0.04 in Q1 2023.
• A 5-year average of 0.14 and a median of 0.09 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio slumped 65.39% in 2023 and surged 451.69% in 2025, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.1 in 2022, then surged by 58.86% to 0.16 in 2023, then slumped by 64.73% to 0.06 in 2024, then surged by 451.69% to 0.32 in 2025, then dropped by 3.67% to 0.31 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.31 (Q1 2026), 0.32 (Q4 2025), and 0.07 (Q3 2025), per Business Quant data.